Cardiac resynchronization therapy (CRT) induces a significant improvement in patients with heart failure (HF), who are often characterized by the presence of endothelial dysfunction (ED) with impaired flow-mediated vasodilation (FMD). We aimed to study the ED in patients with HF candidates to CRT with defibrillator (CRT-D).
Santini, L., Capria, A., DI MOLFETTA, A., Mahfouz, K., Panattoni, G., Minni, V., et al. (2013). Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure. JOURNAL OF CARDIAC FAILURE, 19(6), 419-425 [10.1016/j.cardfail.2013.05.001].
Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure
SANTINI, LUCA;CAPRIA, AMBROGIO;DI MOLFETTA, ARIANNA;SERGI, DOMENICO;ROMEO, FRANCESCO
2013-06-01
Abstract
Cardiac resynchronization therapy (CRT) induces a significant improvement in patients with heart failure (HF), who are often characterized by the presence of endothelial dysfunction (ED) with impaired flow-mediated vasodilation (FMD). We aimed to study the ED in patients with HF candidates to CRT with defibrillator (CRT-D).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Endothelial Dysfunction is a Marker of Systemic Response to the Cardiac Resynchronization Therapy in Heart Failure.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
332.35 kB
Formato
Adobe PDF
|
332.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
